Emvision Medical Devices Ltd has released a press release.
CEO Half-Year Update
Filed with ASX ·
6ix hasn’t read this filing yet.
EMvision Medical Devices Ltd. on 6ix
Story so far
Earlier from EMvision Medical Devices
- Clinical Trial Stage 1 Enrolment Completed
- Trial Progressing on Target and ASA Milestone Achieved
- $8.8m In Non-Dilutive Funding To Be Received This Quarter
- EMVision Commences Clinical Trial
- AGM Chairman Address and Presentation
Later from EMvision Medical Devices
- Product Development Milestones & Grant Funding Achieved
- Stage 2 of Clinical Trial Activated
- Leadership Transition
- $1.75M Manufacturing Grant Payment Received
- Recruitment at Royal Melbourne Hospital Commences
Follow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices